Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a25a2bfc2e9179f3

Jump to content

// Workers AI · dad joke modeWhat did glucose-elevating agent say? I'm a raising agent.

From Wikipedia, the free encyclopedia

Glucose-elevating agents are medications used to treat hypoglycemia (low blood sugar) by raising blood glucose. In diabetics, hypoglycemia can occur as a result of too much insulin or antidiabetic medication, insufficient food intake, or sudden increase in physical activity or exercise. The most common glucose-elevating agents used to treat diabetic hypoglycemia are glucose (in the form of tablets or liquid) and glucagon injections when severe hypoglycemia occurs. Diazoxide, which is used to counter hypoglycemia in disease states such as insulinoma (a tumor producing insulin)[1] or congenital hyperinsulinism, increases blood glucose and decreases insulin secretion and glucagon accelerates breakdown of glycogen in the liver (glycogenolysis) to release glucose into the bloodstream.[2]

List of glucose-elevating agents

[edit]

References

[edit]
  1. Huang, Qin; Bu, Shizhong; Yu, Yongwei; Guo, Zhiyong; Ghatnekar, Gautam; Bu, Min; Yang, Linhui; Lu, Bin; Feng, Zhengkang (January 2007). "Diazoxide Prevents Diabetes through Inhibiting Pancreatic β-Cells from Apoptosis via Bcl-2/Bax Rate and p38-β Mitogen-Activated Protein Kinase". Endocrinology. 148 (1): 81–91. doi:10.1210/en.2006-0738. ISSN 0013-7227. PMID 17053028.
  2. "Glucose-Elevating Agents – Nursing Pharmacology Study Guide". Nurseslabs. 2017-08-10. Retrieved 2018-10-29.